Trade mark cluttering, Olympic logo, EMI amnesty, Crestor and Ariosa – the week in brief
Managing IP is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Trade mark cluttering, Olympic logo, EMI amnesty, Crestor and Ariosa – the week in brief

In this week’s round-up of IP developments, James Nurton reviews trade mark, copyright and patent developments in Europe, Australia, Japan and the United States

Clarity on cluttering

UK IPO logo

The UK IPO has published a study on cluttering and non-use of trade marks in Europe, researched and written by George von Grevenitz, Richard Ashmead and Christine Greenhalgh. Given that the process culminating in the proposal of new EU trade mark legislation is effectively complete (a process that was partly the result of concerns about cluttering) this study might be seen as something of a late arrival.

However, it does provide some useful if not conclusive evidence, based on comparisons between the UK, EU and US systems. Responses from 11 anonymous trade mark practitioners contain both critical and broadly supportive views of the EU system though the report notes that: “Overall the critical voices are stronger” (possibly reflecting the UK’s generally ambiguous relationship with the EU).

Moreover, the 118-page study finds that marks registered at OHIM contain claims to 50% more goods and/or services than identical marks registered at the USPTO, due to the less strict use requirements. That’s no surprise, but future policy makers might find it useful to have it set out in some detail, and with lots of charts.

The study is discussed by Estelle Senior of HGF on the Automotives + IP page on LinkedIn.

Logo falls at first hurdle

Tokyo logo

News outlets including the BBC reported that the 2020 Tokyo Olympic Games logo has been dropped due to plagiarism allegations made by a Belgian artist (see pictures, right).

The withdrawal of the logo, designed by Kenjiro Sano, was described by the BBC as “a highly unusual move”.

Amnesty for music samplers

Sony/ATV is offering an amnesty to artists who have sampled music owned by EMI Production Music. The six-month amnesty, which includes a waiving of retrospective royalties, started on September 1.

EMI Production Music owns a large library of rights to works including various TV theme tunes, which are thought to have been widely sampled in electronic music.

More details are available in the reports in The Independent (“’Sample amnesty’ will let artists keep royalties if they declare material lifted from other musicians”) and the Guardian (“What EMI’s six-month sample amnesty means for the music industry”)

Meanwhile, The Hollywood Reporter brings news that musician Jay Z “doesn’t want his wealth discussed at copyright trial”. He is in court charged with sampling an Egyptian composition in his song “Big Pimpin”, reports Eriq Gardner, but his lawyer wants to exclude evidence relating to what he’s worth, arguing it might cause the jury to make a bigger award. Forbes estimates Jay Z’s wealth at $550 million.

Big news down under

crestor-bottle-shot-250.jpg

Australia’s High Court has upheld a ruling by the lower courts that AstraZeneca’s patent for rosuvastatin (which it sells as Crestor) is invalid for lacking an inventive step. The drug is a statin, used for treating high cholesterol.

In unanimous but separate opinions, the High Court judges found that the claimed invention was obvious in the light of the common general knowledge and the prior art submitted.

An obviousness challenge to the US patent for rosuvastatin failed in the US District Court for Delaware in 2010. AstraZeneca subsequently signed a dealwith Watson Pharmaceuticals. The US patent expires in 2016.

Anger builds over Ariosa

As we have previously noted, Sequenom is seeking an en banc review of the Federal Circuit’s recent decision in its dispute with Ariosa, in which its diagnostic testing patent was invalidated under Section 101. Now, 23 law professors have chimed in with an amicus brief (co-authored by Kevin Noonan of McDonnell Boehnen Hulbert & Berghoff and Adam Mossoff of George Mason University School of Law)

In a post on the IP Watchdog blog, Devlin Hartline argues that the Federal Circuit panel “reached the wrong conclusion” and misapplied the US Supreme Court’s Mayo ruling. Moreover, he says, the decision “strikes at the very heart of the patent system”: “…the panel’s reasoning simply cannot be squared with several innovations that the Supreme Court has historically upheld as proper statutory subject matter.”

Definitely one to watch.

more from across site and ros bottom lb

More from across our site

Ireland joining the UPC would offer plenty of opportunities to local attorneys but there are fears that upcoming referendum could get ‘lost in the noise’
Attorneys at four firms reveal the business opportunities that stem from patent licensing agreements in the life sciences sector
We provide a rundown of Managing IP’s news and analysis from the week, and review what’s been happening elsewhere in IP
Counsel at four firms explain their lateral hiring policies and how they retain existing lawyers
Lori Gordon, who has joined from Perkins Coie, says she hopes to turn Goodwin into a 'premier' destination for PTAB work
The LMG Life Sciences Awards is thrilled to present the shortlist for the 2024 EMEA Awards.
Partners at LeanWill Law Firm, a newly launched domestic firm in China, discuss IP opportunities and which clients they plan to target
Each week Managing IP speaks to a different IP lawyer about their life and career
A survey of more than 25,000 in-house lawyers reveals that embracing technology could help law firms win new business
John Mulgrew, vice president of IP at Lenovo, says the EU's proposed regulation will readdress imbalances in the bargaining power of SEP owners and implementers
Gift this article